Orca Bio

Sr. Specialist, Regulatory Affairs

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

Candidates require a Bachelor’s degree in a life science or adjacent field, with a minimum of 3 years of experience in regulatory affairs supporting clinical trials, and preferred experience in oncology and/or cell therapy. Knowledge of ICH/GCP guidelines and other relevant regulations is essential, along with strong verbal and written communication skills and proficiency in organizational, time management, and interpersonal skills.

Responsibilities

The Sr. Regulatory Affairs Specialist will prepare and process all regulatory documentation for FDA, EMA, and other regulatory bodies, including new submissions, annual reports, amendments, adverse events, and reportable events. They will actively participate in regulatory and cross-functional team meetings, providing advice and support on regulatory aspects of clinical trials, draft study documents such as protocols, informed consent forms, and case report forms, and ensure all study information on ClinicalTrials.gov is current and accurate. Furthermore, they will maintain awareness of evolving FDA and EMA regulations, communicating significant changes to relevant stakeholders.

Skills

Regulatory Documentation
FDA
EMA
Clinical Trials
Regulatory Submissions
ICH/GCP Guidelines
Regulatory Strategies
Protocol Drafting
Informed Consent Forms
ClinicalTrials.gov Management
Regulatory Compliance
Communication Skills
Organizational Skills
Time Management
Interpersonal Skills

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI